Treatment of diabetic nephropathy with an sgc stimulator

AU2026234001A1Pending Publication Date: 2026-10-01CYCLERION THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026234001
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-03-24
Filing Date
2026-09-16
Publication Date
2026-10-01

Smart Images

  • Figure 00000062_0000
    Figure 00000062_0000
  • Figure 00000063_0000
    Figure 00000063_0000
Patent Text Reader

Abstract

The present invention relates to a method of treating subjects with diabetic nephropathy by administering certain dosages of Compound I, a stimulator of soluble guanylate cyclase (sGC), either alone or in combination therapy. N N N N F H N F3C OH CF3 F N O Compound I F H N N OH N N N O F 20 26 23 40 01 16 S ep 2 02 6 2 0 2 6 2 3 4 0 0 1 1 6 S e p 2 0 2 6 F H N N O H N N N O F
Need to check novelty before this filing date? Find Prior Art